Which works best for high potassium? new study tests three emergency options
NCT ID NCT04012138
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study compared three emergency treatments for dangerously high potassium levels: insulin with dextrose, nebulized salbutamol, or a combination of both. Researchers measured how well each lowered potassium within 60 minutes. The trial involved 419 adults in emergency departments to find the safest and most effective approach.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Salbutamol and insulin aspart
What this could lead to
If successful, this trial could identify the most effective first-line treatment for acute hyperkalemia, improving emergency care and reducing complications.
What could go wrong
This is a completed Phase 4 trial, but results may not apply to all patient groups. The treatments have known side effects like low blood sugar or rapid heart rate.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPERKALEMIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Agen Hospital
Agen, France
-
Angers University Hospital
Angers, France
-
Avicenne University Hospital
Bobigny, France
-
La Pitié Salpêtrière University Hospital
Paris, France
-
Lariboisiere Hospital
Paris, France
-
Louis Mourier Hospital
Colombes, France
-
Nancy University Hospital
Nancy, France
-
Nantes University Hospital
Nantes, France
-
Nice University Hospital
Nice, France
-
Poitiers University Hospital
Poitiers, France
-
Rennes University Hospital
Rennes, France
-
Saint Antoine University Hospital
Paris, France
-
Strasbourg University Hospital
Strasbourg, France
-
Tours University Hospital
Tours, France
-
University Hospital, Clermont-Ferrand
Clermont-Ferrand, France
-
University Hospital, Grenoble
Grenoble, France